Wearable technology for pregnant women with Type 1 Diabetes

Research output: Contribution to conferencePosterpeer-review

Abstract

Type 1 Diabetes (T1D) is a chronic auto-immune
condition. Pregnancies in this population are high risk for both mother & baby.
Pregnancy management for women with T1D involves:
Glucose monitoring, 8-12 times daily
Insulin administration, 4-8 times daily
Calculating carbohydrates and matching this to personal insulin/carbohydrate ratios
Participating in regular physical activity (PA). 

Advances in insulin therapy & glucose monitoring help women to achieve safer blood glucose levels during pregnancy. The Topol Report (2019) recommends using technology to enhanced care of chronic conditions enabling greater levels of self-management.
Original languageEnglish
Pages1
Number of pages1
Publication statusPublished (in print/issue) - 8 Jun 2021
Event32nd International Confederation of Midwives Virtual Triennial Congress - Online
Duration: 2 Jun 202130 Jun 2021
https://www.icmvirtualcongress.org/

Conference

Conference32nd International Confederation of Midwives Virtual Triennial Congress
Abbreviated titleICM
Period2/06/2130/06/21
Internet address

Keywords

  • integrating data
  • wearable technologies
  • pregnant women
  • T1D
  • pregnancy
  • maternal outcomes
  • foetal outcomes

Fingerprint

Dive into the research topics of 'Wearable technology for pregnant women with Type 1 Diabetes'. Together they form a unique fingerprint.

Cite this